Three-Month Endothelial Human Endothelin-1 Overexpression Causes Blood Pressure Elevation and Vascular and Kidney Injury

No abstract is available for this paper.

• Publication year

  2018

• Venue

  HYPERTENSION

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.117.09925PMID 29133362
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kidney Injury Molecule-1 is Elevated in Nephropathy and Mediates Macrophage Activation via the Mapk Signalling Pathway

  2017cited by this paper
• The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury

  2017cited by this paper
• Oxidative Stress, Inflammation, and Vascular Aging in Hypertension

  2017cited by this paper
• The role of infiltrating immune cells in dysfunctional adipose tissue

  2017cited by this paper
• The role of chemokines in hypertension and consequent target organ damage

  2017cited by this paper
• Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.

  2016cited by this paper
• Endothelin-1 Overexpression Exaggerates Diabetes-Induced Endothelial Dysfunction by Altering Oxidative Stress.

  2016cited by this paper
• Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation.

  2016cited by this paper
• Endothelin

  2016cited by this paper
• Inducible Human Endothelin-1 Overexpression in Endothelium Raises Blood Pressure via Endothelin Type A Receptors

  2015cited by this paper
• CD36 Mediated Fatty Acid-Induced Podocyte Apoptosis via Oxidative Stress

  2015cited by this paper
• Augmented Vascular Smooth Muscle Cell Stiffness and Adhesion When Hypertension Is Superimposed on Aging

  2015cited by this paper
• Myeloid Suppressor Cells Accumulate and Regulate Blood Pressure in Hypertension.

  2015cited by this paper
• Dual opposing roles of adaptive immunity in hypertension.

  2014cited by this paper
• Innate Immunity in Hypertension

  2014cited by this paper
• CD36 and Na/K-ATPase-&agr;1 Form a Proinflammatory Signaling Loop in Kidney

  2013cited by this paper
• CD36 as a therapeutic target for endothelial dysfunction in stroke.

  2012cited by this paper
• Kim-1/Tim-1 and Immune cells: Shifting Sands

  2012cited by this paper
• Vascular Remodeling in Hypertension: Mechanisms and Treatment

  2012cited by this paper
• T Regulatory Lymphocytes Prevent Aldosterone-Induced Vascular Injury

  2012cited by this paper
• A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

  2012cited by this paper
• T Regulatory Lymphocytes Prevent Angiotensin II–Induced Hypertension and Vascular Injury

  2011cited by this paper
• Regulation of blood pressure and salt homeostasis by endothelin.

  2011cited by this paper
• Low Blood Pressure in Endothelial Cell–Specific Endothelin 1 Knockout Mice

  2010cited by this paper
• Anaphylactic shock depends on endothelial Gq/G11

  2009cited by this paper
• Expression of kidney injury molecule-1 (Kim-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury.

  2009cited by this paper
• A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial.

  2009cited by this paper
• CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD.

  2009cited by this paper
• CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

  2009cited by this paper
• Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells.

  2008cited by this paper
• Vascular endothelin in hypertension.

  2005cited by this paper
• Endothelium-Restricted Overexpression of Human Endothelin-1 Causes Vascular Remodeling and Endothelial Dysfunction

  2004cited by this paper
• Darusentan: an effective endothelinA receptor antagonist for treatment of hypertension.

  2002cited by this paper
• Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases.

  1999cited by this paper
• The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators.

  1998cited by this paper
• Vascular endothelin-1 expression and effect of an endothelin ETA antagonist on structure and function of small arteries from stroke-prone spontaneously hypertensive rats.

  1998cited by this paper
• Enhanced expression of endothelin‐1 gene in resistance arteries in severe human essential hypertension

  1997cited by this paper
• Structure and function of small arteries in salt-induced hypertension: effects of chronic endothelin-subtype-A-receptor blockade.

  1997cited by this paper
• Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats.

  1995cited by this paper
• Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant.

  1994cited by this paper
• Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.

  1994cited by this paper
• Increased plasma endothelin level in patients with essential hypertension.

  1990cited by this paper
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells

  1988cited by this paper
• Renal function curve--a key to understanding the pathogenesis of hypertension.

  1987cited by this paper

• Diagnosis of Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN) based on a Raman-Metabolomics multimodal re-annotated segment hierarchical fusion model.

  2026cites this paper
• Aprocitentan: a new horizon in the treatment of hypertension

  2025cites this paper
• Uncovering immune pathways for therapeutic targeting of hypertension

  2025cites this paper
• Interplay Between the Mineralocorticoid System, Inflammation, Hypertension, and Kidney Disease

  2025cites this paper
• Endothelin antagonists for hypertension: has their time finally arrived?

  2025cites this paper
• Endothelial MicroRNA-214 Confers Angiotensin II Hypertension by Targeting eNOS in Mice

  2025cites this paper
• Research Progress of Arteriosclerosis in Chronic Kidney Disease

  2025cites this paper
• Endothelin receptor antagonists (ERAs) can potentially be used as therapeutic drugs to reduce hypertension caused by small molecule tyrosine kinase inhibitors (TKIs)

  2025cites this paper
• The role of hyperuricemia in the progression of end‐stage kidney disease and its molecular prospective in inflammation and cardiovascular diseases: A general review

  2025cites this paper
• Advances in understanding of the role of immune cell phenotypes in hypertension and associated vascular disease.

  2024cites this paper
• Effects of Cacna1d D307G Mutation on Blood Pressure and Kidney Function in Rats with Salt Loading

  2024influential citation
• New Kids on the Hypertension Block: Novel Agents With New Mechanisms of Action.

  2024cites this paper
• Endothelin System in Hypertension and Chronic Kidney Disease

  2023cites this paper
• Será que a Medição da Big Endotelina-1 Pode Ter um Papel em Pacientes Admitidos Por Enfarte Agudo do Miocárdio sem Supra Desnivelamento do Segmento ST?

  2023cites this paper
• Aprocitentan and the endothelin system in resistant hypertension.

  2022cites this paper
• Endothelial dysfunction as a factor leading to arterial hypertension

  2022cites this paper
• Endothelial and Vascular Smooth Muscle Dysfunction in Hypertension.

  2022cites this paper
• Meta-analysis and trial sequential analysis of shexiang baoxin pill for coronary slow flow

  2022cites this paper
• Research on the Mechanism and Prevention of Hypertension Caused by Apatinib Through the RhoA/ROCK Signaling Pathway in a Mouse Model of Gastric Cancer

  2022cites this paper
• The Effect of Blood Pressure Variability on Coronary Atherosclerosis Plaques

  2022cites this paper
• Acute metabolic effects of metformin during critical illness

  2022cites this paper
• Oxidative Stress and Hypertension

  2021cites this paper
• Male and Female High Fat Fed Dahl SS rats are largely protected from vascular dysfunctions: PVAT contributions reveal sex differences.

  2021cites this paper
• Aldosterone contributes to hypertension in male mice inducibly overexpressing human endothelin-1 in endothelium

  2021influential citation
• Summarizing the Effective Herbs for the Treatment of Hypertensive Nephropathy by Complex Network and Machine Learning

  2021cites this paper
• Association of pre-pro-endothelin gene polymorphism and serum endothelin-1 with intradialytic hypertension in an Egyptian population.

  2020cites this paper
• Effects of combination treatment with amlodipine and telmisartan on blood pressure and inflammatory endothelial factors in patients with primary hypertension

  2020cites this paper
• Research Advances in the Mechanisms of Hyperuricemia-Induced Renal Injury

  2020cites this paper
• Discovery of a novel analogue of FR901533 and the corresponding biosynthetic gene cluster from Streptosporangium roseum No. 79089

  2020cites this paper
• [Mechanisms of chronic stress influence on the brain hemodynamic in persons with employment-related chronic stress].

  2020cites this paper
• Phenylethanol Glycosides Protect Myocardial Hypertrophy Induced by Abdominal Aortic Constriction via ECE-1 Demethylation Inhibition and PI3K/PKB/eNOS Pathway Enhancement

  2020cites this paper
• Oxidative Stress: A Unifying Paradigm in Hypertension

  2020cites this paper
• How Structure, Mechanics, and Function of the Vasculature Contribute to Blood Pressure Elevation in Hypertension.

  2020cites this paper
• Hypertension and Heart Failure: Epidemiology, Mechanisms and Treatment

  2020cites this paper
• Metformin Preconditioning and Postconditioning to Reduce Ischemia Reperfusion Injury in an Isolated Ex Vivo Rat and Porcine Kidney Normothermic Machine Perfusion Model

  2020cites this paper
• Heart-Microcirculation Connection

  2020cites this paper
• Immune Mechanisms in Vascular Remodeling in Hypertension

  2020cites this paper
• Chronic Elevation of Endothelin-1 Alone May Not Be Sufficient to Impair Endothelium-Dependent Relaxation.

  2019cites this paper
• Intrauterine Growth Restriction Programs Intergenerational Transmission of Pulmonary Arterial Hypertension and Endothelial Dysfunction via Sperm Epigenetic Modifications.

  2019cites this paper
• Developments in the Role of Endothelin-1 in Atherosclerosis: A Potential Therapeutic Target?

  2019cites this paper
• Opposite alterations of endothelin-1 in lung and pulmonary artery mirror gene expression of bone morphogenetic protein receptor 2 in experimental pulmonary hypertension

  2019cites this paper
• Endothelin and the heart in health and diseases

  2019cites this paper
• Less Vertebral Bone Mass after Treatment with Macitentan in Mice: A Pilot Study

  2019cites this paper
• Arterial stiffness in chronic kidney disease: a modifiable cardiovascular risk factor?

  2019cites this paper
• Associations of EDNRA and EDNRB polymorphisms with intracerebral hemorrhage.

  2019cites this paper
• Endothelin: 30 Years From Discovery to Therapy.

  2019cites this paper
• Association between big endothelin-1 and CHADS2/CHA2DS2-VASc scores in non-valvular atrial fibrillation

  2019cites this paper
• The PKCβ‐p66shc‐NADPH oxidase pathway plays a crucial role in diabetic nephropathy

  2018cites this paper
• Reduced expression of microRNA-199a-3p is associated with vascular endothelial cell injury induced by type 2 diabetes mellitus.

  2018cites this paper
• Does Endothelin-1 Raise or Lower Blood Pressure in Humans?

  2018cites this paper
• Improvements in SOD mimic AEOL-10150, a potent broad-spectrum antioxidant

  2018cites this paper
• New drugs and emerging therapeutic targets in the endothelin signaling pathway and prospects for personalized precision medicine.

  2018cites this paper
• Neprilysin inhibition and endothelin‐1 elevation: Focus on the kidney

  2018cites this paper
• (online) The relationship of genetic risk factors with the development of arterial hypertension taking into account ethnic

  year unknowncites this paper
• Arteriosclerosis, Thrombosis, and Vascular Biology

  year unknowncites this paper